Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice

Abstract

Liver cancer is one of the top six leading causes of cancer-related death. Radiofrequency ablation (RFA) is an important means of treating liver cancer. Residual cancer after RFA is the most frequent cause of recurrence in cases of liver cancer. The main difference between residual cancer cells and ordinary liver cancer cells is that residual cancer cells experience heat shock. The secretable form of trimeric human tumor necrosis factor-related apoptosis-inducing ligand (stTRAIL) induces apoptosis in a variety of human cancers but not in normal tissues. It has shown potent cancer-selective killing activity and has drawn considerable attention as a possible cancer therapy. In the present work, the therapeutic potential of this stTRAIL-based gene therapy was evaluated in hepatocellular carcinoma subjected to RFA. Rat bone marrow mesenchymal stem cells (BM-MSCs) were isolated and transduced with a lentiviral vector encoding stTRAIL (stTRAIL-MSCs, T-MSCs). Cells treated with heat treatment at 43 °C for 45 min served as simulated residual cancer cells. After treatment with T-MSCs, apoptosis in heat-shock-treated liver cancer cells increased significantly, and caspase-3 was upregulated. When T-MSCs were subcutaneously injected into nude mice, they localized to the tumors and inhibited tumor growth, significantly increasing survival. Collectively, the results of the present study indicate that BM-MSC can provide a steady source of stTRAIL and may be suitable for use in the prevention of the recurrence of hepatocellular carcinoma after RFA with secretable trimeric TRAIL.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

    Article  Google Scholar 

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893–2917.

    Article  CAS  Google Scholar 

  3. Nordlinger B, Van Cutsem E, Rougier P, Kohne CH, Ychou M, Sobrero A et al. Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 2007; 43: 2037–2045.

    Article  CAS  Google Scholar 

  4. Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010; 252: 903–912.

    Article  Google Scholar 

  5. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L . Local recurrence after hepatic radiofrequency coagulation - Multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242: 158–171.

    Article  Google Scholar 

  6. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A . Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271: 12687–12690.

    Article  CAS  Google Scholar 

  7. Kim MH, Billiar TR, Seol DW . The secretable form of trimeric TRAIL, a potent inducer of apoptosis. Biochem Biophys Res Commun 2004; 321: 930–935.

    Article  CAS  Google Scholar 

  8. Jeong M, Kwon YS, Park SH, Kim CY, Jeun SS, Song KW . Possible novel therapy for malignant gliomas with secretable trimeric TRAIL. PloS One 2009; 4: e4545.

    Article  Google Scholar 

  9. Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Cancer Res 2008; 68: 9614–9623.

    Article  CAS  Google Scholar 

  10. Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP et al. Cancer gene therapy using a novel secretable trimeric TRAIL. Gene Ther 2006; 13: 330–338.

    Article  CAS  Google Scholar 

  11. Yoo J, Lee YJ . Effect of hyperthermia and chemotherapeutic agents on TRAIL-induced cell death in human colon cancer cells. J Cell Biochem 2008; 103: 98–109.

    Article  CAS  Google Scholar 

  12. Aquino JB, Bolontrade MF, Garcia MG, Podhajcer OL, Mazzolini G . Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. Gene Ther 2010; 17: 692–708.

    Article  CAS  Google Scholar 

  13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315–317.

    Article  CAS  Google Scholar 

  14. Secchiero P, Melloni E, Corallini F, Beltrami AP, Alviano F, Milani D et al. Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells. Stem Cells 2008; 26: 2955–2963.

    Article  CAS  Google Scholar 

  15. Jo M, Kim TH, Seol DW, Esplen JE, Dorko K, Billiar TR . Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 2000; 6: 654–657.

    Article  Google Scholar 

  16. Nitsch R, Bechmann I, Deisz RA, Haas D, Lehmann TN, Wendling U . Human brain cell death induced by tumour-necros is-factor-related apoptosis-inducing ligand (TRAIL). Lancet 2000; 356: 827–828.

    Article  CAS  Google Scholar 

  17. Grisendi G, Bussolari R, Cafarelli L, Petak I, Rasini V, Veronesi E et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res 2010; 70: 3718–3729.

    Article  CAS  Google Scholar 

  18. Pal S, Sadhu AS, Patra S, Mukherjea KK . Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models. J Exp Clin Cancer Res 2008; 27: 68.

    Article  Google Scholar 

  19. Shao R, Shi Z, Gotwals PJ, Koteliansky VE, George J, Rockey DC . Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Biol Cell 2003; 14: 2327–2341.

    Article  CAS  Google Scholar 

  20. Poon RT, Borys N . Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009; 10: 333–343.

    Article  CAS  Google Scholar 

  21. Haaga JR, Exner AA, Wang Y, Stowe NT, Tarcha PJ . Combined tumor therapy by using radiofrequency ablation and 5-FU-laden polymer implants: evaluation in rats and rabbits. Radiology 2006; 237: 911–918.

    Article  Google Scholar 

  22. Habibi M, Kmieciak M, Graham L, Morales JK, Bear HD, Manjili MH . Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis. Breast Cancer Res Treat 2009; 114: 423–431.

    Article  Google Scholar 

  23. Zhang Y, Qu ZH, Cui M, Guo C, Zhang XM, Ma CH . Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice.pdf. Cancer Biol Ther 2009; 8: 466–473.

    Article  CAS  Google Scholar 

  24. Lin ZY, Chen J, Deng XF . Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. Eur J Radiol 2012; 81: 3079–3083.

    Article  Google Scholar 

  25. Kim CY, Park SH, Jeong M, Kwon OS, Doh H, Kang SH et al. Preclinical studies for pharmacokinetics and biodistribution of Ad-stTRAIL, an adenovirus delivering secretable trimeric TRAIL for gene therapy. Exp Mol Med 2011; 43: 580–586.

    Article  CAS  Google Scholar 

  26. Wood BJ, Locklin JK, Dreher MR, Ng KK, Eugeni M . Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol 2012; 23: 248–255.

    Article  Google Scholar 

  27. Shore GC, Nguyen M . Bcl-2 proteins and apoptosis: choose your partner. Cell 2008; 135: 1004–1006.

    Article  CAS  Google Scholar 

  28. Rai R, Richardson C, Flecknell P, Robertson H, Burt A, Manas DM . Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). J Surg Res 2005; 129: 147–151.

    Article  CAS  Google Scholar 

  29. Nijkamp MW, van der Bilt JD, de Bruijn MT, Molenaar IQ, Voest EE, van Diest PJ et al. Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg 2009; 249: 814–823.

    Article  Google Scholar 

  30. Ichikawa K, Liu W, Zhao L, Wang Z, Liu D, Ohtsuka T . Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 2001; 7: 954–960.

    Article  CAS  Google Scholar 

  31. Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M . Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 2000; 32: 482–490.

    Article  CAS  Google Scholar 

  32. Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011; 19: 257–272.

    Article  CAS  Google Scholar 

  33. Luk JM, Wang PP, Lee CK, Wang JH, Fan ST . Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. JImmunol Methods 2005; 305: 39–47.

    Article  CAS  Google Scholar 

  34. Kang XQ, Zang WJ, Song TS, Xu XL, Yu XJ, Li DL et al. Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. World J Gastroenterol 2005; 11: 3479–3484.

    Article  Google Scholar 

  35. Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402–408.

    Article  CAS  Google Scholar 

  36. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M . Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 2000; 87: 595–600.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Yanmin Xu for help with the lentiviral transduction and Qiang Zhang for statistics analysis. This work was supported by two grants from the surface project of the National Natural Science Foundation of the People’s Republic of China (No. 30972894 and 81272688).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Ma.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deng, Q., Zhang, Z., Feng, X. et al. TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice. Gene Ther 21, 317–327 (2014). https://doi.org/10.1038/gt.2013.88

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2013.88

Keywords

This article is cited by

Search

Quick links